Introduction: Gynecologic Cancers are the most common cancers in women, in 2012, Cervical Cancer (CC) is ranking as the fourth with an estimated 528.000 new cases and Ovarian Cancer (OC) is the seventh most common for females with nearly 239.000 new cases worldwide.

Aim: this communication presents the latest international descriptive epidemiological data for invasive GC, including incidence, survival and mortality in the worldwide.

Methods: -The incidence and mortality statistics presented for GC worldwide were taken from the International Agency for Research on Cancer IARC: * the Cancer Incidence in five Continents Vol X and * GLOBOCAN database, 2012.

-The data of cancer survival are taken from: * Cancer survival in five continents, a worldwide population-based study (CONCORD) version 2, 1995-2009. Estimated five-year net survival, adjusted for background mortality by single year of age, sex, calendar year in each country.

Results: CC is the most common cancer among women in 45 countries mainly in sub-Saharan Africa, part of Asia and some countries in Central and South America, the lowest incidence rates in western Europe, North America, Australia and the eastern Mediterranean. Almost 55% of all new cases of OC occurred in countries very high level of human development mainly northern Europe and America and Oceanic, Africa presents the lowest incidence.

-Data for CC are available for 602 225 women, CC survival was 50% or higher in most countries, except for Libya (Benghazi, 39%) and India (Karunagappally, 46%). During 2005-09, age-standardised 5-year net survival was 70% or higher in Iceland, Mauritius, Norway, South Korea, and Taiwan, for Qatar is also above 70% (based on only 16 cases and is not age-standardised).

-Data for ovarian cancer are available for 779 302 women, during 2005-09, age-standardised 5-year net survival was 40% or higher in Ecuador, the USA, nine countries in Asia, and eight countries in Europe. Survival in other countries was mostly in the range 30-40%, except for Libya (22%).

Conclusions: The evolution of cancers in women shows a consistent and very striking pattern during the epidemiological transition with rapid declines in the incidence of cervical cancer. Comparison of population-based cancer survival CONCORD study 2 showed very wide variations in survival from gynecologic cancer worldwide.

Note: This abstract was not presented at the meeting.

Citation Format: Zoubida Zaidi, Mokhtar Hamdi Cherif. The descriptive epidemiology of gynecologic cancers: an international comparison of incidence, survival and mortality [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 269. doi:10.1158/1538-7445.AM2017-269